Illicit psychoactive substance use, abuse and dependence in a population-based sample of Norwegian twins.
- Authors
- Kendler, Kenneth S; Aggen, Steven H; Tambs, Kristian; Reichborn-Kjennerud, Ted
- Year
- 2006
- Journal
- Psychological medicine
- PMID
- 16650346
- DOI
- 10.1017/S0033291706007720
- PMCID
- PMC1945097
BACKGROUND: Prior population-based twin studies from two Anglophonic countries with relatively high rates of drug use - the USA and Australia - suggest that genetic factors contribute substantially to individual differences in the use, abuse and dependence of illicit psychoactive substances. Would these results replicate in Norway, a Nordic country with a low prevalence of illicit drug use? METHOD: Lifetime use, abuse and dependence of five illicit drug categories (cannabis, stimulants, opiates, cocaine and psychedelics) were assessed at personal interview in 1386 complete young adult twin pairs ascertained from the Norwegian Institute of Public Health Twin Panel. Twin model fitting was performed using the Mx statistical package on three phenotypes: any lifetime use, endorsement of at least one DSM-IV symptom of abuse or dependence, and meeting DSM-IV criteria for abuse or dependence. RESULTS: Significant lifetime use of illicit substances (defined as use 10 or more times) was reported by only 6.4% of the sample. Meaningful analyses were possible for use of any substance and each of the five substances individually, but for symptoms or a diagnosis of abuse/dependence meaningful analyses were possible only for any substance and cannabis. Full twin models uniformly found twin resemblance to be due largely or entirely to genetic factors. Best-fit models for all analyses included only genetic and individual-specific environmental effects with heritability estimates ranging from 58% to 81%. CONCLUSION: In accord with prior results from the USA and Australia, genetic factors appear to play an important role in the etiology of use and abuse/dependence of illicit drugs in Norway.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
| Filename | Size | Added | |
|---|---|---|---|
| 16650346.pdf | 126649 bytes | 2026-05-15 | View |
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Genome-wide association study of cocaine self-administration behavior in Heterogeneous Stock rats | Lara MK et al. | — | 2025 | — |
| Differential etiologic associations of heroin use and prescription opioid misuse with psychopathology. | Dash GF et al. | — | 2024 | → |
| Common genetic and environmental risk for personality disorders and psychotic-like experiences in young adult twins. | Tesli M et al. | — | 2023 | → |
| Specificity in genetic and environmental risk for prescription opioid misuse and heroin use. | Dash GF et al. | — | 2023 | → |
| Are prescription misuse and illicit drug use etiologically distinct? A genetically-informed analysis of opioids and stimulants. | Dash GF et al. | — | 2022 | → |
| Molecular genetics of cocaine use disorders in humans. | Fernàndez-Castillo N et al. | — | 2022 | → |
| The Use of <i>Drosophila</i> to Understand Psychostimulant Responses. | Philyaw TJ et al. | — | 2022 | → |
| Alcohol and drug use disorders in adult attention-deficit/hyperactivity disorder: Prevalence and associations with attention-deficit/hyperactivity disorder symptom severity and emotional dysregulation. | Anker E et al. | — | 2020 | → |
| Neuroepigenetics and addiction. | Walker DM et al. | — | 2018 | → |
| Rescue the child or treat the adult? Understandings among professionals in dual treatment of substance-use disorders and parenting. | Wiig EM et al. | — | 2018 | → |
| The genetic and environmental architecture of substance use development from early adolescence into young adulthood: a longitudinal twin study of comorbidity of alcohol, tobacco and illicit drug use. | Waaktaar T et al. | — | 2018 | → |
| Cannabis and Depression: A Twin Model Approach to Co-morbidity. | Smolkina M et al. | — | 2017 | → |
| Genetic and Environmental Contributions to the Association Between Cannabis Use and Psychotic-Like Experiences in Young Adult Twins. | Nesvåg R et al. | — | 2017 | → |
| Amphetamine self-administration and dopamine function: assessment of gene × environment interactions in Lewis and Fischer 344 rats. | Meyer AC et al. | — | 2015 | → |
| Early age of alcohol initiation is not the cause of alcohol use disorders in adulthood, but is a major indicator of genetic risk. A population-based twin study. | Ystrom E et al. | — | 2014 | → |
| A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5. | Verweij KJ et al. | — | 2013 | → |
| Genetic variation of the ghrelin signalling system in individuals with amphetamine dependence. | Suchankova P et al. | — | 2013 | → |
| The association between prescribed opioid use for mothers and children: a record-linkage study. | Log T et al. | — | 2013 | → |
| Epidemiology of substance use disorders. | Merikangas KR et al. | — | 2012 | → |
| Gambling, disordered gambling and their association with major depression and substance use: a web-based cohort and twin-sibling study. | Blanco C et al. | — | 2012 | → |
| Levels of aggressiveness are higher among alcohol-related suicides: results from a psychological autopsy study. | Chachamovich E et al. | — | 2012 | → |
| Common genetic influences on depression, alcohol, and substance use disorders in Mexican-American families. | Olvera RL et al. | — | 2011 | → |
| Genome-wide association study in bipolar patients stratified by co-morbidity. | Kerner B et al. | — | 2011 | → |
| Psychiatric 'diseases' versus behavioral disorders and degree of genetic influence. | Bienvenu OJ et al. | — | 2011 | → |
| The AVPR1A gene and substance use disorders: association, replication, and functional evidence. | Maher BS et al. | — | 2011 | → |
| The joint structure of DSM-IV Axis I and Axis II disorders. | Røysamb E et al. | — | 2011 | → |
| The structure of genetic and environmental risk factors for syndromal and subsyndromal common DSM-IV axis I and all axis II disorders. | Kendler KS et al. | — | 2011 | → |
| Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies. | Verweij KJ et al. | — | 2010 | → |
| Addiction genetics and pleiotropic effects of common haplotypes that make polygenic contributions to vulnerability to substance dependence. | Uhl GR et al. | — | 2009 | → |
| Assessing the heritability of anorexia nervosa symptoms using a marginal maximal likelihood approach. | Mazzeo SE et al. | — | 2009 | → |
| Candidate genes for cannabis use disorders: findings, challenges and directions. | Agrawal A et al. | — | 2009 | → |
| Externalizing disorders: cluster 5 of the proposed meta-structure for DSM-V and ICD-11. | Krueger RF et al. | — | 2009 | → |
| Smoking and smoking cessation in disadvantaged women: assessing genetic contributions. | Uhl GR et al. | — | 2009 | → |
| Structure of genetic and environmental risk factors for dimensional representations of DSM-IV anxiety disorders. | Tambs K et al. | — | 2009 | → |
| Addiction Reviews. Preface. | Uhl GR | — | 2008 | → |
| Are there genetic influences on addiction: evidence from family, adoption and twin studies. | Agrawal A et al. | — | 2008 | → |
| Behavioral disinhibition and the development of early-onset addiction: common and specific influences. | Iacono WG et al. | — | 2008 | → |
| "Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice. | Uhl GR et al. | — | 2008 | → |
| Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects. | Uhl GR et al. | — | 2008 | → |
| Substance use risk across three generations: the roles of parent discipline practices and inhibitory control. | Pears K et al. | — | 2007 | → |